Keyphrases
Advanced Hybrid Closed Loop
62%
Automated Insulin Delivery
29%
Basal Insulin
8%
Bolus
8%
Children with Type 1 Diabetes
8%
Closed-loop Algorithm
9%
Continuous Glucose Monitor
9%
Continuous Glucose Monitoring
32%
Continuous Subcutaneous Insulin Infusion
35%
Diabetes
14%
Diabetes Technology
12%
Differentiated Thyroid Carcinoma
9%
During Pregnancy
10%
Glucose Control
11%
Glucose Management Indicator
12%
Glycemic Control
45%
Glycemic Targets
8%
Hemoglobin A1c (HbA1c)
31%
Hybrid Closed Loop
8%
Hypoglycemia
24%
Hypoglycemia Risk
15%
Insulin
28%
Insulin Pump
27%
Insulin Pump Therapy
29%
Insulin Resistance
11%
Insulin Sensitivity
12%
Intact Parathyroid Hormone (iPTH)
8%
Intermittently Scanned Continuous Glucose Monitoring (isCGM)
11%
Israel
9%
Living with
10%
Medtronic
13%
MiniMed 780G
45%
Multiple Daily Injections
34%
National Audit Project
9%
Pregestational Diabetes
9%
Quality of Life
12%
Randomized Controlled Trial
13%
Randomized Trial
8%
Self-monitoring of Blood Glucose
9%
Sensor-augmented Pump
11%
Sensor-augmented Pump Therapy
8%
Severe Hypoglycemia
8%
System User
8%
Tight
8%
Time in Range
29%
Treatment Satisfaction
8%
Type 1 Diabetes Mellitus (T1DM)
100%
Type 2 Diabetes Mellitus (T2DM)
30%
Type 2 Diabetic Patients
21%
Type I Diabetes
76%
Medicine and Dentistry
Anesthesiologist
6%
Antidiabetic Agent
7%
Arm
9%
Birth Weight
7%
Blood Glucose
8%
Body Mass Index
6%
Cardiovascular System
5%
Clinical Trial
6%
Cost-Effectiveness Analysis
7%
Diabetes
38%
Diabetes Mellitus
21%
Differentiated Thyroid Cancer
7%
Diseases
5%
Gestational Diabetes
9%
Glycated Hemoglobin
9%
Glycemic
12%
Glycemic Control
22%
Health Care Cost
6%
Heart Arrest
7%
Hemoglobin A1c
24%
Hyperglycemia
5%
Hypoglycemia
29%
Hypothyroidism
6%
Insulin Dependent Diabetes Mellitus
60%
Insulin Infusion
27%
Insulin Pump
43%
Insulin Sensitivity
10%
Maturity Onset Diabetes of the Young
18%
Parathyroid Hormone
6%
Patient with Type 2 Diabetes
6%
Personal Data
7%
Radioactive Iodine
7%
Randomized Controlled Trial
10%
Thyrotropin
8%
